Correlation Engine 2.0
Clear Search sequence regions


  • child (2)
  • children (2)
  • community (6)
  • humans (1)
  • patients (1)
  • physician (1)
  • pneumonia (6)
  • Sizes of these terms reflect their relevance to your search.

    Despite availability of several official guidelines, not all the problems related to the most effective and safe use of antibiotics in children with community-acquired pneumonia (CAP) have been solved. Presently, too many children receive unneeded antibiotics or, when antibiotics are mandatory, the choice of the drug is not appropriate. In this paper, the authors discuss the remaining unsolved problems for rational antibiotic therapy use in pediatric community-acquired pneumonia and provide their expert perspectives. Further improvement in pediatric CAP management could be derived from physician education on antibiotic use and a larger use, particularly in office practice, of point of care testing or new technologies (i.e. artificial intelligence) to define etiology of a lower respiratory infection. However, recommendations regarding the duration of antibiotic therapy vary largely because of the absence of reliable data on the optimal CAP treatment according to the bacterial etiology of the disease, its severity, and child characteristics. Available evidence seems to confirm that a short course of antibiotics, approximately 5 days, can be effective and lead to results not substantially different from those obtained with prolonged-course antibiotic therapy, at least in patients with mild to moderate disease.

    Citation

    Susanna Esposito, Alberto Argentiero, Francesca Rebecchi, Valentina Fainardi, Giovanna Pisi, Nicola Principi. The remaining unsolved problems for rational antibiotic therapy use in pediatric community-acquired pneumonia. Expert opinion on pharmacotherapy. 2022 Mar;23(4):497-505

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35094614

    View Full Text